Viant Integrates with PurpleLab™
17 Januar 2024 - 3:10PM
Business Wire
Setting a new standard for measurement
solutions and advanced analytics in healthcare
advertising
Viant Technology Inc. (NASDAQ: DSP), the leading people-based
advertising technology company, today announced a new integration
with PurpleLab™, a healthcare analytics company that holds one of
the largest medical and pharmaceutical claims databases in the US,
to create an unparalleled measurement solution for healthcare
marketers.
With the healthcare industry constituting a substantial 17% of
the U.S. GDP1 and healthcare spending in digital advertising set to
grow at double-digit rates2, the need for a robust measurement
solution is paramount for healthcare marketers. Viant's integration
with PurpleLab™ promises to empower healthcare brands and
advertisers by providing access to closed-loop, de-identified
measurement and reporting all in a single platform.
“Both Viant and PurpleLab continue to innovate, particularly in
the areas of data, cookieless measurement, and analytics, and this
integration will enable healthcare brands to better optimize their
campaigns and gain valuable insights for prescription optimization,
healthcare providers, and physician-level data,” said Tara Nanda,
Vice President, Addressable Strategy and Activation at KINESSO.
Through this integration, Viant will provide advertisers with
advanced healthcare analytics, leveraging PurpleLab's extensive
claims database, HealthNexus, their expertise in evaluating
provider performance, and Viant’s cookieless Household ID. The
result will be a comprehensive and sophisticated measurement
solution aggregating prescription optimization, healthcare
providers (HCP), and physician-level data.
“PurpleLab is excited to partner with Viant. Our integration
will give healthcare brands and advertisers access to an advanced
measurement solution, enabling them to make more informed
decisions, reshape campaign messaging, target more effectively, and
drive better patient outcomes in the healthcare industry,” said
Mark Brosso, founder and CEO of PurpleLab.
ABOUT VIANT
Viant® (NASDAQ: DSP) is a leading people-based, advertising
technology company that enables marketers to plan, execute and
measure omnichannel ad campaigns through a cloud-based platform.
Viant’s self-service Demand Side Platform powers programmatic
advertising across Connected TV, Linear TV, mobile, desktop, audio,
gaming and digital out-of-home channels. As an organization
committed to sustainability, Viant’s Adricity® carbon reduction
program helps clients achieve their sustainability goals. In the
past year, Viant was recognized by G2 as a Leader in the DSP
category and as the Best Software in Marketing & Advertising,
earned Great Place to Work® certification, and became a founding
member of Ad Net Zero. Viant’s Co-Founders Tim and Chris Vanderhook
are also past recipients of EY’s Entrepreneurs of the Year award.
To learn more, please visit viantinc.com.
ABOUT PURPLELAB
PurpleLab™ is a healthcare analytics company with a mission to
spur value-driven innovation across the healthcare continuum.
HealthNexus™, the company's no-code analytics platform empowers
life science, payers, providers, and other healthcare stakeholders
to develop real-world evidence (RWE) that novel therapeutics or
clinical strategies are performing, leading to savings in lives and
costs. PurpleLab, who raised a Series B financing of $40M on July
2022, has also been certified as one of the few CMS Qualified
Entities, enabling them to receive Medicare claims data under Parts
A, B, and D to evaluate provider performance. For more information,
visit purplelab.com.
___________________________ 1 Centers for Medicare and Medicaid
Services (CMS), 2022 2 Source: Insider Intelligence | eMarketer,
August 2023
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240117896125/en/
Media: Marielle Lyon press@viantinc.com
Viant Technology (NASDAQ:DSP)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Viant Technology (NASDAQ:DSP)
Historical Stock Chart
Von Jun 2023 bis Jun 2024